Recent research has shown that FDG-PET scans can be helpful in distinguishing malignant from benign lesions, differentiating MPNSTs from neurofibromas with an 80% specificity and almost 100% sensitivity [25, 26], which is why an NF1 consensus does recommend performing it [22]. This evidence concerns the gene NF1 and plexiform neurofibroma.